Breast Cancer Coverage from Every Angle

Published Medical Literature

Insurance and Mortality in Breast and Other Cancers
Final Results of MARIANNE Trial of T-DM1 in HER2-Positive Advanced Breast Cancer
Menopausal Hormone Replacement Therapy and Increased Risk of Breast Cancer
Niraparib Plus Pembrolizumab in Advanced Triple-Negative Breast Cancer
Learning More About Breast Cancer in Adolescents and Young Adults
Breast Cancer Screening in Women With Familial Risk: MRI or Mammography?
Timeliness of Chemotherapy Initiation After Breast Cancer Diagnosis and Survival
TAILORx Trial: Predicting Benefit From Chemotherapy in Early Breast Cancer
Adjuvant Trastuzumab for HER2-Positive Breast Cancer: Results of Two Phase III Trials
HannaH Trial: Subcutaneous Versus Intravenous Trastuzumab in Early Breast Cancer
Role of Lymphoscintigraphy in Sentinel Lymph Node Biopsy for Early Breast Cancer
Pain and Depression in Patients Treated for Breast Cancer
Parity-Associated Gene Expression and Breast Cancer in Premenopausal Women
How an Intervention Trial Addressed Racial Disparities in Treatment of Early-Stage Cancers
Targeting Triple-Negative Breast Cancer With Combination of PARP Inhibitors
Overall Survival With CDK4/6 Inhibitor in Hormone Receptor–Positive Breast Cancer
Niraparib Plus Pembrolizumab in Triple-Negative Breast Cancer: TOPACIO/KEYNOTE-162 Trial
Lifetime Incidence of Brain Metastasis in Elderly Survivors of Breast Cancer
Long-Term Outcomes With Adjuvant Paclitaxel and Trastuzumab in HER2-Positive Breast Cancer
Eribulin Versus Vinorelbine in Locally Recurrent or Metastatic Breast Cancer
Does Primary Care Appointment Time Affect Breast Cancer Screening Rates?
Chronic Opioid Use in Breast Cancer Survivors
Potential Prognostic Marker Identified for Triple Negative Breast Cancer
Genetic Testing in Patients With Breast and Ovarian Cancers
Preoperative Breast MRI and Surgical Outcomes in Local Ductal Carcinoma in Situ
Linking Pregnancy and the Genomic Landscape of Subsequent Breast Cancer
Breast Cancer Risk in Women With BRCA Mutations: Role of Number of Pregnancies
Addition of First-Line Fulvestrant to Anastrozole in Metastatic Breast Cancer
Long-Term Follow-up of Adjuvant Tamoxifen in Women With Breast Cancer
KAMILLA Trial: T-DM1 Safety in HER2-Positive Breast Cancer
Complications After Immediate Implant-Based Breast Cancer Reconstruction
Can Celecoxib Be Used to Treat HER2-Negative Breast Cancer?
Ovarian Function Suppression in Women With Breast Cancer: Degarelix Versus Triptorelin
Extended Letrozole Therapy After Aromatase Inhibitor–Based Therapy in Breast Cancer
Survival Outcomes With Palbociclib and Fulvestrant in Breast Cancer
Addition of Palbociclib to Letrozole in Estrogen Receptor–Positive Breast Cancer
Is There a Link Between Childbirth and Breast Cancer Risk?
Anthracycline Use in Neoadjuvant Therapy for HER2-Positive Breast Cancer
Axillary Radiotherapy as an Alternative to Axillary Lymph Node Dissection for Early Breast Cancer
Cosmetic Outcomes With Irradiation in Stages 0 to II Breast Cancer
Novel Statistical Approach Calculates Risk of Breast Cancer Recurrence in American Women
Extending Aromatase Inhibitor Therapy in Breast Cancer
Continued Benefit of Adding Goserelin to Chemotherapy in Women With Breast Cancer
Combination of Paclitaxel, Sorafenib, and Radiation in Advanced Breast Cancer
Lucitanib for Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
PALB2 Mutation in Hereditary Breast and Ovarian Cancer
How Accurate Are NCDB Comorbidity Assessments in Breast Cancer and Other Resected Tumors?
Racial Differences in Adherence to Endocrine Therapy for Breast Cancer
Update on Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors
Atezolizumab in Metastatic Triple-Negative Breast Cancer: Long-Term Outcomes
Population-Level Genomic Screening for Hereditary Breast Cancer
Alliance Study: Comparing Neoadjuvant Therapy Approaches in HER2-Positive Breast Cancer
Are Fertility-Related Hormone and Breast Cancer Development Linked?
Novel Tool to Predict Risk of Late Distant Recurrence in Patients With Breast Cancer
Update on Trends in Breast Cancer Survival Among Young Women
Impact of Screening on Breast Cancer Mortality Assessed in Danish Study
Can Circulating Tumor Cells Predict Late Recurrence in Breast Cancer?
Long-Term Safety Profile of Palbociclib With Endocrine Therapy
ASCO Clinical Practice Guidelines Updates in Advanced HER2-Positive Breast Cancer
Neoadjuvant Chemotherapy Plus Panitumumab in Inflammatory Breast Cancer
ASCO Guideline Update: Adjuvant Chemotherapy and Targeted Therapy for Breast Cancer
Fear and Worry Over Breast Cancer Among Women Facing Surgical Decisions
Comparing Trastuzumab Biosimilar and Reference Trastuzumab in HER2-Positive Breast Cancer
Update to ASCO/CAP Guidelines on HER2 Testing in Breast Cancer
Association of Prognosis in Early Breast Cancer With Somatic Driver Alterations
Safety of Pregnancy After Estrogen Receptor–Positive Breast Cancer
Clinical Relevance of Multigene Sequencing in Patients With Breast Cancer
Are Long-Term Survivors of Triple-Negative Breast Cancer Being Referred for Genetic Counseling?
Link Between CTC Status and Radiotherapy Benefit in Early-Stage Breast Cancer
Screening for Intracranial Disease in Patients With Metastatic Breast Cancer
Cardiovascular Risks Associated With Breast Cancer and Its Treatments
Are Patients Diagnosed With Breast Cancer Receiving Clinically Indicated Genetic Counseling?
Disparities in Genetic Testing for Hereditary Breast Cancer in the United States
Is Hormone Therapy a Risk Factor for Diabetes in Breast Cancer Survivors?
Novel Second-Line Treatment of Aromatase Inhibitor–Resistant Breast Cancer
Genetic Biomarker as Potential Predictor of Platinum Sensitivity in Triple-Negative Breast Cancer
Addition of Veliparib to Standard Neoadjuvant Therapy in Triple-Negative Breast Cancer
Predicting Risk of Breast Cancer: Automated Versus Clinical Assessment of Breast Density
Postmastectomy Radiation Therapy for Locoregional Control of Breast Cancer
CALOR Trial: Adjuvant Chemotherapy for Isolated Locoregional Recurrence of Breast Cancer
Use of Metronomic Chemotherapy in Older Patients With Metastatic Breast Cancer
Bone Turnover Markers in Metastatic Breast Cancer
Combination Therapy Under Study in Treatment-Resistant Breast Cancer
First-Degree Family History and Breast Cancer Risk in Women Older Than Age 65
Androgen Receptor–Targeted Treatment in Triple-Negative Breast Cancer
Distant and Locoregional Recurrence in Stage II or III Breast Cancer
Updated Results on Neratinib in HER2-Positive Breast Cancer
Correlation Between Breast Cancer Mortality and Advances in Screening and Treatment
Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer
Dual HER2 Blockade in Metastatic Breast Cancer
Pertuzumab-Containing Neoadjuvant Regimens in HER2-Positive Breast Cancer
Dual HER2-Targeting Treatments for Postmenopausal Women With Metastatic Breast Cancer
Hormonal Birth Control and Invasive Breast Cancer Risk
Safety Profile of Buparlisib Plus Fulvestrant in Advanced Breast Cancer
Survival Benefit of Intense Dose-Dense Chemotherapy in High-Risk Breast Cancer
Use of Duloxetine for Arthralgias Associated With Breast Cancer Treatment
Letrozole Schedules Compared in Postmenopausal Women With Breast Cancer
Textured Breast Implants and Rare Anaplastic Lymphoma
Type 2 Diabetes and Breast Cancer Subtype in African American Women
Cardiac Effects of Trastuzumab Therapy in Patients With HER2-Positive Breast Cancer
Bacterial Imbalances and Breast Cancer
Initial Therapy With Abemaciclib for Advanced Breast Cancer
Effect of 5 Years’ Endocrine Therapy on Breast Cancer Recurrence
cT1–2N0 Breast Cancer: Less- and More-Invasive Treatment Results
Mortality in Elderly, Mentally Ill Breast Cancer Patients
Physicians’ Views on Radiotherapy for Older Women With Early-Stage Breast Cancer
Neoadjuvant Combination Therapy for HER2-Positive Primary Breast Cancer
HER2-Targeted Therapy and Breast Reconstruction
Soy Foods and Breast Cancer Survival
Surgeon Impact on the Decision to Have Contralateral Prophylactic Mastectomy
Investigational AKT Inhibitor in Triple-Negative Breast Cancer
Neoadjuvant Ado-trastuzumab Emtansine vs. Trastuzumab in Early Breast Cancer
Tamoxifen Metabolite Z-Endoxifen in Metastatic Breast Cancer
Current Treatment Approaches for Triple-Negative Breast Cancer
Response to Immunotherapy in Patients With ‘Claudin-Low’ Breast Tumors
Comparing Trastuzumab-Based Regimens in Older Women With Early-Stage Breast Cancer
Surveillance Mammography for Older Survivors of Breast Cancer
Wound Complications After Breast Reconstruction Procedures
Potential Toxicities Associated With CDK4/6 Inhibitors in Breast Cancer
Using Molecular Signature to Identify Indolent Breast Tumors
Oral Vinorelbine in Patients With Endocrine-Pretreated Breast Cancer
Changes in Histology and Breast Cancer Risk
MONARCH 2: Abemaciclib/Fulvestrant in Hormone Receptor–Positive, HER2-Negative Breast Cancer
Adding Pertuzumab to Trastuzumab and Chemotherapy in HER2-Positive Breast Cancer
Final Survival Data From TH3RESA Trial in Breast Cancer
Final Overall Survival Data From EMILIA Trial
Biologic Differences in Invasive Breast Cancers Among Black and White Patients
OlympiAD Trial: Olaparib in HER2-Negative Metastatic Breast Cancer
Additional Surgery After Initial Lumpectomy
Patient Satisfaction With Breast Reconstruction
More Women Living With Metastatic Breast Cancer
Combining Monoclonal Antibodies in HER2-Positive Breast Cancer
ABC Breast Cancer Trials of Adjuvant Taxane With or Without Anthracycline in HER2-Negative Disease
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Optimizing Adherence to Oral Chemotherapy
Steadily Increasing Breast Cancer Rates in Asian Americans
Study Finds Discrepant Decision-Making for Use of 21-Gene Assay in Women With Early-Stage Breast Cancer
Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
Contralateral Prophylactic Mastectomy Decisions in Patients With Early-Stage Breast Cancer
Identifying Educational Needs of the Multidisciplinary Cancer Team in the Treatment of Metastatic Breast Cancer
A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer
Improved Survival With Higher TIL Values in Advanced HER2-Positive Breast Cancer
A Review of Treatment for Breast Cancer–Related Lymphedema: Paradigms for Clinical Practice
Stereotactic Radiosurgery for Treatment of Brain Metastases

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.